Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1
US6214791A · kind A · utility
63Cited by
6References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 12, 2000 |
| Grant date | Apr 10, 2001 |
| Priority date | — |
| Expiry date | Jan 12, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the treatment of multiple sclerosis by ingestion or inhalation of copolymet-1 and pharmaceutical compositions useful for such treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.